Results 121 to 130 of about 14,077 (253)

Role of magnetic resonance imaging in the differentiation of mucinous ovarian carcinoma and mucinous borderline ovarian tumors. [PDF]

Rev Assoc Med Bras (1992), 2023
Hasbay E, Görgülü G, Sanci M, Özamrak BG.   +3 more
europepmc   +1 more source

Pebbled mosaic‐like heterogeneous echogenicity in ovarian immature teratomas and correlation of ultrasound patterns with pathological grades

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
This study characterizes heterogeneous mottled grayscale ultrasound echoes of ovarian immature teratoma as the “pebbled mosaic sign,” noting solid lesions correlate with advanced pathological grades. Preoperative identification of immature tissue informs operative stratification. Abstract Introduction Ovarian immature teratomas (ITs) are rare malignant
Tianyu Zhang, Jie Yang, Xiaohua Shi, Zhenzhen Liu, Dan Wang, Yang Zhou, Na Su, Jiaxin Yang   +7 more
wiley   +1 more source

Post-ovarian cystectomy imaging appearances for borderline ovarian tumors: Pearls and pitfalls. [PDF]

J Clin Imaging Sci
Kuo BJ, Chin FHX, Chew SH, Lau LC.
europepmc   +1 more source

Effects of Infertility Drug Exposure on the Risk of Borderline Ovarian Tumors: A Systematic Review and Meta-Analysis. [PDF]

Biomedicines, 2023
Si M, Wang X, Song X, Long X, Qiao J.
europepmc   +1 more source

Gold‐standard evidence and best practice guidance for menstrual cycle‐informed clinical care: An overview for clinicians

British Journal of Clinical Psychology, EarlyView.
Abstract Objectives To synthesize current evidence and provide clinically actionable recommendations for integrating menstrual cycle‐related processes—particularly hormone sensitivity, Premenstrual Dysphoric Disorder (PMDD) and Premenstrual Exacerbation (PME)—into psychological assessment, formulation and treatment.
Ellen R. Lambert, Louise N. Nolan, Katja M. Schmalenberger   +2 more
wiley   +1 more source

Oncofertility outcomes after fertility-sparing surgery for borderline ovarian tumors: results of a large retrospective study. [PDF]

J Ovarian Res
Wang R, Xiao Y, Fernando T, Chen Y, Zhu X.   +4 more
europepmc   +1 more source

Management of Borderline ovarian tumors (BOT): results of a retrospective, single center study in Switzerland. [PDF]

J Ovarian Res, 2023
Kipp B, Vidal A, Lenick D, Christmann-Schmid C.   +3 more
europepmc   +1 more source

The nitty‐gritty of vascular permeability in cancer: targeting blood endothelium to control metastases

British Journal of Pharmacology, EarlyView.
Blood vascular permeability is a hallmark of cancer and acts as an active driver of metastatic dissemination. Metastasis accounts for the vast majority of cancer deaths, yet most work has focussed on tumour‐intrinsic traits and angiogenesis, while the specific contribution of endothelial barrier regulation to intravasation and extravasation remains ...
Pierre Boucher, Mérone Da Costa Oliveira, Adrien Levesque, Alexandre Rutault, Patrick Savoyaud, Nicolas Bréchot, Stéphane Germain   +6 more
wiley   +1 more source

Characteristics and outcomes of patients with endometriosis and malignant or borderline ovarian tumors: real-world evidence from an ESGO centre of excellence. [PDF]

BMC Cancer
Beck MH, Kordowitzki P, Roser E, Trelinska-Finger A, Schoof E, Chinczewski L, Mechsner S, Sehouli J.   +7 more
europepmc   +1 more source

Management of borderline ovarian tumors: A tertiary referral center experience in Egypt. [PDF]

Front Surg, 2022
Gaballa K, Abdelkhalek M, Fathi A, Refky B, Belal K, Elaraby M, Zuhdy M.   +6 more
europepmc   +1 more source